TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 1 | 0 | 8 | 6 | 49 | 50 | 2 | 23 |
| S | %wins | 100 | 0 | 0 | 0 | 0 | 0 | 17 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/11/13 18:12 | 8/19/13 | HALO | Halozyme Therapeutics Inc | DE | Health | BioPrd | Biological Products, (No Diag | Shepard H. Michael | CA | O | VP,Chief | S | -71 | 7.11 | 12 | -10 | -43 | 13 | D | 41 | 53 | 62 | 39 | 12 | 30 | 12 | 5 | 0 | 8 | 6 | 49 | 50 | 2 |
2/5/13 20:20 | 2/2/13 | HALO | Halozyme Therapeutics Inc | DE | Health | BioPrd | Biological Products, (No Diag | Shepard H. Michael | CA | O | VP,Chief | M | 0 | 0.00 | 11 | 12 | 103 | 23 | D | -5 | -42 | -23 | 22 | 19 | -21 | -21 | -8 | 2 | -4 | -15 | -5 | 12 | 112 |
5/17/12 16:27 | 5/15/12 | HALO | Halozyme Therapeutics Inc | DE | Health | BioPrd | Biological Products, (No Diag | Shepard H. Michael | CA | O | VP,Chief | M | 0 | 0.00 | 7 | 11 | New | 11 | D | 4 | 13 | -8 | -34 | -41 | -8 | -5 | 0 | 5 | 7 | 18 | -21 | -30 | 0 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |